Aditxt Inc. (ADTX) stock forecast · rev $3.2K
Aditxt Inc. (ADTX) is a biotechnology company listed on NASDAQ.
This ADTX forecast page states what the cached financials imply — not a price target and not a guarantee. Aditxt Inc. outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported ADTX revenue for 2025-12-31 was $3.2K. Net income was -$43.1M. Revenue was down 97.6% from 2024-12-31 to 2025-12-31. ADTX currently screens at market cap $3.6K.
The near-term path: Revenue was down 97.6% from 2024-12-31 to 2025-12-31. A forecast that ignores that change is just a story.
ADTX currently screens at market cap $3.6K. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ADTX 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ADTX stock page.
Not investment advice.